Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.

Brewer CA, Blessing JA, Nagourney RA, Morgan M, Hanjani P.

Gynecol Oncol. 2006 Nov;103(2):446-50. Epub 2006 Apr 27.

PMID:
16643994
2.

Optimizing gemcitabine regimens in ovarian cancer.

Pecorelli S, Pasinetti B, Tisi G, Odicino F.

Semin Oncol. 2006 Apr;33(2 Suppl 6):S17-25. Review.

PMID:
16716799
3.

Gemcitabine in patients with ovarian cancer.

Poveda A.

Cancer Treat Rev. 2005;31 Suppl 4:S29-37. Review.

PMID:
16360545
4.

Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma.

Rose PG.

Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:18-22. Review.

PMID:
15839954
5.

Second-line treatment of ovarian cancer with single-agent gemcitabine.

Markman M.

Semin Oncol. 2002 Feb;29(1 Suppl 1):9-10. Review.

PMID:
11840414
6.

Gemcitabine in cisplatin-resistant ovarian cancer.

Lund B, Neijt JP.

Semin Oncol. 1996 Oct;23(5 Suppl 10):72-6. Review.

PMID:
8893886

Supplemental Content

Support Center